HF 284
Status in the House - 91st Legislature (2019 - 2020)
Revisor number: 19-1917
Description
Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.
Authors
Actions
House
| 01/22/2019 | |
| 01/24/2019 |
Authors added
Loeffler and Dehn
pg. 120
|
| 03/11/2019 |
Committee report, to adopt as amended and re-refer to
Health and Human Services Policy
pg. 937a
|
| 03/13/2019 |
Committee report, to adopt and re-refer to
Judiciary Finance and Civil Law Division
pg. 1013
|
| 03/20/2019 |
Author added
Persell
pg. 1510
|
| 04/01/2019 |
Author added
Bierman
pg. 1785
|
| House Actions | Senate Actions |
|---|---|
| 01/22/2019 | |
| 01/24/2019 | |
|
Authors added
Loeffler and Dehn
pg. 120
|
|
| 03/11/2019 | |
|
Committee report, to adopt as amended and re-refer to
Health and Human Services Policy
pg. 937a
|
|
| 03/13/2019 | |
|
Committee report, to adopt and re-refer to
Judiciary Finance and Civil Law Division
pg. 1013
|
|
| 03/20/2019 | |
|
Author added
Persell
pg. 1510
|
|
| 04/01/2019 | |
|
Author added
Bierman
pg. 1785
|
|